The vaccine ETF (159643) rose slightly by 0.2%, and the premium trading in the market, Kailei rose more than 5%

Kai La Ying rose more than 4%, and Baipusus, Tiger Medicine, Dian Diagnosis, etc. rose.The vaccine ETF (159643) rose slightly by 0.2%, and the turnover exceeded 24 million yuan.

Anxin Securities believes that with the normalization of normalization, the global and Chinese vaccine market may return to the path of growth of heavy varieties. Among my country's current non -immunization planning vaccines, a variety of new vaccines and multi -price vaccines (such as such as such as HPV vaccine, multi -combined seedlings, 13 -valent pneumonia combined vaccine, tetravalent flu vaccine, third -generation rabies vaccine, etc.) are in the rapid volume period. With the domestic high -priced HPV vaccine, shingles vaccine, and triple seedlings in the next few years. 13 Valenture pneumonia combined with vaccine, three -generation rabies vaccine, and quasal influenza vaccines have increased by the number of enterprises in batch, and my country's vaccine industry is expected to continue to grow.

- END -